Alexander Hunter is a Producer at CNN. He focuses on themes related to publishing and media, with a particular interest in commodities markets, commodity trading, and derivatives markets. His work has been featured in BioRxiv, CBS News, The Washington Times, and various Wiley publications.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Alexander's work primarily comprises opinion editorials and press releases, with a focus on culture & society, entertainment news, world affairs, and design. His coverage includes topics such as politics, freedom of speech, show business, justice and family.
When reaching out to Alexander Hunter for collaboration or pitching story ideas that align with his coverage attributes and themes covered it would be best to offer unique perspectives on cultural trends in the US or provide insightful commentary on current events related to politics or social issues. Additionally, pitches involving expert opinions within the entertainment industry could also resonate well with him.
Given his national focus on the United States and emphasis on opinion pieces about culture & society along with political matters , any contributions should aim to provide fresh insights into these areas specifically relevant to an American audience.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Illustration by Alexander Hunter for The Washington Times (published November 21, 2025)
Illustration by Alexander Hunter for The Washington Times (published December 5, 2025)
Illustration by Alexander Hunter for The Washington Times (published December 10, 2025)
Illustration by Alexander Hunter for The Washington Times (published December 17, 2025)
Illustration by Alexander Hunter for The Washington Times (published April 1, 2026)
Illustration by Alexander Hunter for The Washington Times (published April 16, 2026)
Illustration by Alexander Hunter for The Washington Times (published April 27, 2026)
By: Alexander Hunter, Quan Huynh, Jennifer S. Stettler, Jennifer Stettler, Nauman Ashraf, Christopher Stewart, Dawny M. Barnhart, Faith Franzwa
Introduction: Clozapine is the most effective antipsychotic for treatment-resistant schizophrenia but remains underutilized due to safety concerns and monitoring complexity. Recent discontinuation of the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program reduced regulatory barriers but shifted responsibility for monitoring to clinicians. Psychiatry residents may lack adequate training and confidence to prescribe clozapine safely in this new context. The goal of this study is to evaluate the impact of a structured educational intervention on psychiatry residents’ knowledge of clozapine prescribing and management.Methods: This study was a single-institution quality improvement study using a pre-post design. Participants were psychiatry residents from PGY-1 to PGY-4. Participants underwent a one-hour structured educational session covering clozapine pharmacology, indications, monitoring, adverse effects, and post-REMS management. Outcomes assessed include knowledge assessment scores both before and after the educational session. A paired t-test comparing pre- and post-intervention scores was used to analyze the data.Results: Ten residents completed both assessments. Mean knowledge scores increased from 69.4% to 82.8% (mean increase 13.4 percentage points (19.3% relative increase); p < 0.05).Conclusions: A brief, targeted educational intervention was associated with improved psychiatry residents’ knowledge regarding clozapine prescribing and management. Focused resident education may help mitigate barriers to clozapine use, particularly following REMS discontinuation. Incorporating structured clozapine training into residency curricula may promote safer and more appropriate use of clozapine in clinical practice.
Illustration by Alexander Hunter for The Washington Times (published May 13, 2026)
By: Alexander Hunter
Illustration by Alexander Hunter for The Washington Times (published July 20, 2026)
